scholarly journals Lasmiditan in patients with common migraine comorbidities: a post hoc efficacy and safety analysis of two phase 3 randomized clinical trials

2020 ◽  
Vol 36 (11) ◽  
pp. 1791-1806 ◽  
Author(s):  
David B. Clemow ◽  
Simin K. Baygani ◽  
Paula M. Hauck ◽  
Cory B. Hultman
Sign in / Sign up

Export Citation Format

Share Document